ROCKET PHARMACEUTICALS, INC. Contracts & Agreements

Underwriting Agreement, dated December 10, 2024, among Rocket Pharmaceuticals, Inc. and Morgan Stanley & Co. LLC, Leerink Partners LLC and Cantor Fitzgerald & Co., as... (Filed With SEC on December 12, 2024)

Offer Letter, dated March 25, 2024 by and between the registrant and Aaron Ondrey (Filed With SEC on May 7, 2024)

PROPRIETARY INFORMATION, INVENTIONS AND NON-SOLICITATION/NON-COMPETITION AGREEMENT (Filed With SEC on February 27, 2024)

ROCKET PHARMACEUTICALS, INC. GENERAL COMPENSATION CLAWBACK POLICY AMENDED AND RESTATED EFFECTIVE SEPTEMBER 25, 2023 (Filed With SEC on February 27, 2024)

Underwriting Agreement, dated September 12, 2023, among Rocket Pharmaceuticals, Inc. and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, Leerink Partners LLC and Cowen and... (Filed With SEC on September 15, 2023)

Form of Pre-Funded Warrant (Filed With SEC on September 15, 2023)

Amendment No. 1 to Sales Agreement, dated as of September 12, 2023, between Rocket Pharmaceutical Inc. and Cowen and Company, LLC (Filed With SEC on September 13, 2023)

Severance and Change in Control Policy, effective as of February 14, 2023 (Filed With SEC on August 9, 2023)

Underwriting Agreement, dated October 3, 2022, among Rocket Pharmaceuticals, Inc. and Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and SVB Securities LLC, as... (Filed With SEC on October 4, 2022)

Agreement and Plan of Merger, dated September 19, 2022, by and among Parent, the Company, Merger Sub I and Merger Sub II (Filed With SEC on September 20, 2022)

Sales Agreement, dated February 28, 2022, by and between the Company and Cowen and Company, LLC (Filed With SEC on March 1, 2022)

Offer Letter, dated September 29, 2017, by and between the Registrant and Raj Prabhakar (Filed With SEC on February 28, 2022)

Offer Letter, dated April 29, 2021, by and between the registrant and Isabel Carmona (Filed With SEC on February 28, 2022)

Warrant to Purchase Shares of Common Stock, dated as of December 17, 2021, by and between the Registrant and Neptune Consulting, LLC. (First Indication) (Filed With SEC on February 28, 2022)

Warrant to Purchase Shares of Common Stock, dated as of December 17, 2021, by and between the Registrant and Neptune Consulting, LLC. (Second Indication) (Filed With SEC on February 28, 2022)

Securities Purchase Agreement, dated as of August 27, 2021, between Rocket Pharmaceuticals, Inc. and the purchaser party thereto (Filed With SEC on August 30, 2021)

Registration Rights Agreement, dated as of August 27, 2021, between Rocket Pharmaceuticals, Inc. and the purchaser party thereto (Filed With SEC on August 30, 2021)

Description of Securities (Filed With SEC on March 1, 2021)

Offer Letter, dated November 25, 2020, by and between the registrant and Carlos Garcia-Parada (Filed With SEC on March 1, 2021)

Warrant to Purchase Shares of Common Stock dated as of December 21, 2020, by and between the Registrant and Neptune Consulting, LLC (Filed With SEC on March 1, 2021)

Underwriting Agreement, dated December 9, 2020, among Rocket Pharmaceuticals, Inc., J.P. Morgan Securities LLC, BofA Securities, Inc., SVB Leerink LLC and Piper Sandler & Co (Filed With SEC on December 11, 2020)

Consulting Agreement between the Registrant and Gotham Makker, MD, dated June 16, 2020 (Filed With SEC on August 5, 2020)

Second Supplemental Indenture, dated as of February 20, 2020, between Rocket Pharmaceuticals, Inc. and Wilmington Trust, National Association, as trustee (incorporated by... (Filed With SEC on June 12, 2020)

Offer Letter, dated September 25, 2019, by and between the registrant and Kamran Alam (Filed With SEC on March 6, 2020)

Form of Restricted Stock Unit Award Agreement (Filed With SEC on March 6, 2020)

Second Supplemental Indenture, dated as of February 20, 2020, between Rocket Pharmaceuticals, Inc. and Wilmington Trust, National Association, as trustee (Filed With SEC on February 20, 2020)

Amendment to First Supplemental Indenture, dated as of February 18, 2020, between Rocket Pharmaceuticals, Inc. and Wilmington Trust, National Association, as trustee (Filed With SEC on February 20, 2020)

Form of Exchange Agreement (Filed With SEC on February 11, 2020)

Underwriting Agreement, dated December 10, 2019, among Rocket Pharmaceuticals, Inc., J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C (Filed With SEC on December 13, 2019)

Amended and Restated Lease Agreement, dated as of June 26, 2019, by and between Rocket Pharmaceuticals, Inc. and Cedar Brook 12 Corporate Center, L.P (Filed With SEC on August 8, 2019)

Underwriting Agreement, dated April 15, 2019, among Rocket Pharmaceuticals, Inc., SVB Leerink LLC, Evercore Group L.L.C. and William Blair & Company, L.L.C (Filed With SEC on April 18, 2019)

License Agreement, dated as of November 19, 2018, by and between Rocket Pharmaceuticals, Ltd. and REGENXBIO Inc (Filed With SEC on March 8, 2019)

Form of Severance and Change of Control Agreements, to be entered into between the Registrant and certain of its officers (Filed With SEC on March 8, 2019)

Underwriting Agreement, dated November 27, 2018, among Rocket Pharmaceuticals, Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Cowen and Company, LLC and Evercore Group... (Filed With SEC on November 29, 2018)

Subscription Agreement, dated November 27, 2018, between Rocket Pharmaceuticals, Inc. and RTW Innovation Master Fund, Ltd (Filed With SEC on November 29, 2018)

Lease Agreement, dated as of August 14, 2018, by and between Rocket Pharmaceuticals, Inc. and Cedar Brook 12 Corporate Center, L.P (Filed With SEC on November 9, 2018)

Amendment No. 1 to the Lease Agreement, dated as of June 28, 2018, by and between Rocket Pharmaceuticals, Ltd. and ARE-East River Science Park, LLC (Filed With SEC on August 14, 2018)

Form of Incentive Stock Option Agreement (Employees) (Filed With SEC on August 14, 2018)

Form of Non-Qualified Stock Option Agreement (Employees) (Filed With SEC on August 14, 2018)

Form of Non-Qualified Stock Option Agreement (Non-Employee Directors) (Filed With SEC on August 14, 2018)

Form of Non-Qualified Stock Option Agreement (Consultants) (Filed With SEC on August 14, 2018)

Agreement of Lease, dated as of June 6, 2018, by and between Rocket Pharmaceuticals, Inc. and ESRT Empire State Building, L.L.C (Filed With SEC on August 14, 2018)

Rocket Pharmaceuticals, Inc. Second Amended and Restated 2014 Stock Option and Incentive Plan (Filed With SEC on June 25, 2018)

Amended and Restated 2014 Stock Option and Incentive Plan and forms of agreements thereunder (Filed With SEC on March 7, 2018)

Rocket Pharmaceuticals, Ltd. 2015 Share Option Plan (Filed With SEC on March 7, 2018)

Letter Agreement, dated as of January 4, 2018, by and between Inotek Pharmaceuticals Corporation and Dale Ritter (Filed With SEC on March 7, 2018)

ROCKET PHARMACEUTICALS, INC. AMENDED AND RESTATED 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on March 7, 2018)

Lease Agreement, dated as of March 31, 2016, by and between Rocket Pharmaceuticals, Ltd. and ARE-East River Science Park, LLC (Filed With SEC on March 7, 2018)

Underwriting Agreement, dated January 24, 2018, among Rocket Pharmaceuticals, Inc., Cowen and Company, LLC and Evercore Group L.L.C (Filed With SEC on January 25, 2018)

Form of Officer Indemnification Agreement (Filed With SEC on January 5, 2018)

Form of the Companys Stock Certificate (Filed With SEC on January 5, 2018)

Form of Director Indemnification Agreement (Filed With SEC on January 5, 2018)

Form of Retention Bonus Letter (Filed With SEC on November 8, 2017)

Agreement and Plan of Merger and Reorganization, dated as of September 12, 2017, by and among Inotek Pharmaceuticals Corporation, Rocket Pharmaceuticals, Ltd. and Rome Merger Sub (Filed With SEC on September 13, 2017)

Amendment to Offer Letter, effective as of September 12, 2017, by and between Inotek and Rudolf A. Baumgartner, MD (Filed With SEC on September 13, 2017)

Amendment to Offer Letter, effective as of September 1, 2017, by and between the Company and Dale Ritter (Filed With SEC on September 1, 2017)

Amendment to Offer Letter, effective as of September 1, 2017, by and between the Company and David Southwell (Filed With SEC on September 1, 2017)

AMENDMENT TO OFFER LETTER (Filed With SEC on August 8, 2017)

INOTEKPHARMACEUTICALS CORPORATION, Issuer AND WILMINGTON TRUST, NATIONAL ASSOCIATION, Trustee INDENTURE Dated as of August 5, 2016 Senior DebtSecurities TABLE OF CONTENTS (Filed With SEC on August 5, 2016)

INOTEKPHARMACEUTICALS CORPORATION AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTALINDENTURE Dated as of August 5, 2016 to Indenture for Senior Debt... (Filed With SEC on August 5, 2016)

Inotek Pharmaceuticals Corporation 5.75% Convertible Senior Notes Due 2021 UNDERWRITING AGREEMENT (Filed With SEC on August 3, 2016)

FIRST AMENDMENT TO LEASE (Filed With SEC on February 26, 2016)

4,500,000 InotekPharmaceuticals Corporation Common Stock UNDERWRITING AGREEMENT (Filed With SEC on August 10, 2015)

INOTEK PHARMACEUTICALS CORPORATION AMENDED AND RESTATED 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on July 31, 2015)

INOTEK PHARMACEUTICALS CORPORATION AMENDED AND RESTATED 2014 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on July 31, 2015)

LEASE 91HARTWELL AVENUE LEXINGTON, MASSACHUSETTS Lease Dated May 29, 2015 (Filed With SEC on June 2, 2015)

INOTEK PHARMACEUTICALS CORPORATION 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on March 31, 2015)

INOTEKPHARMACEUTICALS CORPORATION WARRANT TO PURCHASE SHARES OF SERIES PREFERRED STOCK (LoanA) (Filed With SEC on March 31, 2015)

INOTEK PHARMACEUTICALS CORPORATION AMENDED AND RESTATED 2014 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on March 31, 2015)

Additional abbreviations may also be used though not in the above list. For Value Received, hereby sell, assign and transfer unto (Filed With SEC on March 31, 2015)

LEASE Landlord: Farley White Kilnbrook Three, LLC Tenant: Inotek PharmaceuticalsCorporation Date of Lease: May 11th, 2012 TABLE OF CONTENTS (Filed With SEC on March 31, 2015)

INOTEKPHARMACEUTICALS CORPORATION WARRANT TO PURCHASE SHARES OF SERIES PREFERRED STOCK (LoanB) (Filed With SEC on March 31, 2015)

INOTEK PHARMACEUTICALS CORPORATION AND WILMINGTON TRUST, NATIONALASSOCIATION, as Trustee INDENTURE Dated as ofFebruary 23, 2015 5.0% Convertible Senior Notes due 2020 TABLE OF... (Filed With SEC on February 26, 2015)

INOTEK PHARMACEUTICALS CORPORATION 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on February 17, 2015)

INOTEK PHARMACEUTICALSCORPORATION AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee INDENTURE Datedas of February [ ], 2015 [ . ]% ConvertibleSenior Notes due 2020 TABLE OF... (Filed With SEC on February 17, 2015)

INOTEK PHARMACEUTICALS CORPORATION AMENDED AND RESTATED 2014 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on February 17, 2015)

INOTEK PHARMACEUTICALS CORPORATION 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on January 22, 2015)

INOTEK PHARMACEUTICALS CORPORATION AMENDED AND RESTATED 2014 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on January 22, 2015)

INOTEK PHARMACEUTICALSCORPORATION AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee INDENTURE Datedas of February [ ], 2015 [ . ]% ConvertibleSenior Notes due 2020 TABLE OF... (Filed With SEC on January 22, 2015)

Inotek Pharmaceuticals Corporation [ ]% Convertible Senior Notes Due 2020 UNDERWRITING AGREEMENT (Filed With SEC on January 22, 2015)

[Number of Shares] Inotek Pharmaceuticals Corporation Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 22, 2015)

INOTEK PHARMACEUTICALSCORPORATION AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee INDENTURE Datedas of December [ ], 2014 [ . ]% Convertible Senior Notes due 2019 TABLE OF... (Filed With SEC on January 14, 2015)

INOTEK PHARMACEUTICALS CORPORATION FORM OF OFFICER INDEMNIFICATION AGREEMENT (Filed With SEC on November 21, 2014)

INOTEK PHARMACEUTICALS CORPORATION FORM OF DIRECTOR INDEMNIFICATION AGREEMENT (Filed With SEC on November 21, 2014)

Exhibit A. Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement (Filed With SEC on November 21, 2014)

Exhibit 1 Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement (Filed With SEC on November 5, 2014)

THIRD AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on November 5, 2014)

SCHEDULE 1 TERMINATION CERTIFICATION (Filed With SEC on November 5, 2014)

VENTURE LOAN AND SECURITY AGREEMENT (Filed With SEC on November 5, 2014)

LEASE Landlord: Farley White Kilnbrook Three, LLC Tenant: Inotek PharmaceuticalsCorporation Date of Lease: May 11th, 2012 TABLE OF CONTENTS (Filed With SEC on November 5, 2014)

INOTEK PHARMACEUTICALS CORPORATION AMENDMENT NO. 1 TO THE THIRD AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on November 5, 2014)

INOTEK PHARMACEUTICALS CORPORATION 2004 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on November 5, 2014)

THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on November 5, 2014)

Category

Industry

Companies

Contracts

ROCKET PHARMACEUTICALS, INC. Contracts & Agreements